Literature DB >> 19415305

ABCB1 gene polymorphisms and haplotype analysis in colorectal cancer.

Mariusz Panczyk1, Ewa Balcerczak, Sylwester Piaskowski, Krzysztof Jamroziak, Grazyna Pasz-Walczak, Marek Mirowski.   

Abstract

PURPOSE: The aim of this study was to determine the significance of three most common single-nucleotide polymorphisms (SNPs) of ABCB1 gene in the development of colorectal cancer and to estimate the influence of these SNPs to surviving patients' treatment combination adjuvant therapy 5-fluorouracil/leucovorin. Haplotype structure of ABCB1 was analysed, and degree of linkage disequilibrium (LD) between SNPs of ABCB1 was estimated.
MATERIALS AND METHODS: Tumour specimens of 95 patients with colorectal cancer and blood samples of 95 healthy cases were studied. Genotyping of ABCB1 gene was performed by automated sequencing or polymerase chain reaction-restriction fragment length polymorphism method. Comparison of frequencies of alleles/genotypes/haplotypes between the studied group (colorectal cancer samples) and the control group (blood samples) were analysed. These results were correlated with the surviving patients after treatment of adjuvant chemotherapy.
RESULTS: Significant differences in ABCB1 (1236C>T) (p = 0.00043) and ABCB1 (2677G>T/A) (p = 0.04) genotype distribution and T(1236) allele distribution (CT(1236) or TT(1236) vs CC(1236); p = 0.0499, OR = 0.55, Fi-Yule coefficient = 0.14) were found. A strong LD between ABCB1 (1236C>T) and ABCB1 (2677G>T/A) SNPs (D' = 0.621, r (2) = 0.318) was detected. All SNPs were located in one haplotype block. There were significant differences in haplotype distributions between colorectal cancer patients and healthy population (p = 0.03). Significant differences in survival probability of colorectal cancer patients' treatment chemotherapy according to allele of ABCB1 (3435C>T) was observed. Survival probability of patients with wild-type C(3435) allele were higher than among patients without this allele (p = 0.04572).
CONCLUSIONS: These results suggested that three studied SNPs of ABCB1 were located in one haplotype block. Differences in ABCB1 (1236C>T) and ABCB1 (2677G>T/A) genotypes and T(1236) allele distribution between investigated populations indicate significant impact of these SNPs on risk of development of colorectal cancer. Polymorphism ABCB1 (3435C>T) may be a prediction marker of cancer chemotherapy effectiveness. Differences in haplotype distributions between colorectal cancer patients and healthy population suggested that other potential SNPs, especially in regulatory region of ABCB1 gene, may influence P-glycoprotein expression and function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19415305     DOI: 10.1007/s00384-009-0724-0

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  48 in total

Review 1.  Biochemical, cellular, and pharmacological aspects of the multidrug transporter.

Authors:  S V Ambudkar; S Dey; C A Hrycyna; M Ramachandra; I Pastan; M M Gottesman
Journal:  Annu Rev Pharmacol Toxicol       Date:  1999       Impact factor: 13.820

Review 2.  Pharmacogenetics of drug transporters and its impact on the pharmacotherapy.

Authors:  Toshiyuki Sakaeda; Tsutomu Nakamura; Katsuhiko Okumura
Journal:  Curr Top Med Chem       Date:  2004       Impact factor: 3.295

Review 3.  Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?

Authors:  Sharlene Gill; Frank A Sinicrope
Journal:  Semin Oncol       Date:  2005-02       Impact factor: 4.929

4.  A mutation in the promoter of the multidrug resistance gene (MDR1) in human hematological malignancies may contribute to the pathogenesis of resistant disease.

Authors:  D Rund; I Azar; O Shperling
Journal:  Adv Exp Med Biol       Date:  1999       Impact factor: 2.622

5.  Testing for linkage disequilibrium in genotypic data using the Expectation-Maximization algorithm.

Authors:  M Slatkin; L Excoffier
Journal:  Heredity (Edinb)       Date:  1996-04       Impact factor: 3.821

Review 6.  Pharmacogenetics of MDR1 and its impact on the pharmacokinetics and pharmacodynamics of drugs.

Authors:  Toshiyuki Sakaeda; Tsutomu Nakamura; Katsuhiko Okumura
Journal:  Pharmacogenomics       Date:  2003-07       Impact factor: 2.533

7.  Detection of the four sequence variations of MDR1 gene using TaqMan MGB probe based real-time PCR and haplotype analysis in healthy Japanese subjects.

Authors:  Katsuhiko Saito; Sachie Miyake; Hiroyuki Moriya; Miyuki Yamazaki; Fumio Itoh; Kohzoh Imai; Nahoko Kurosawa; Eiji Owada; Atsushi Miyamoto
Journal:  Clin Biochem       Date:  2003-10       Impact factor: 3.281

8.  MDR1 single nucleotide polymorphism C3435T in normal colorectal tissue and colorectal carcinomas detected by MALDI-TOF mass spectrometry.

Authors:  A Humeny; F Rödel; C Rödel; R Sauer; L Füzesi; C Becker; T Efferth
Journal:  Anticancer Res       Date:  2003 May-Jun       Impact factor: 2.480

9.  Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene.

Authors:  Deanna L Kroetz; Christiane Pauli-Magnus; Laura M Hodges; Conrad C Huang; Michiko Kawamoto; Susan J Johns; Doug Stryke; Thomas E Ferrin; Joseph DeYoung; Travis Taylor; Elaine J Carlson; Ira Herskowitz; Kathleen M Giacomini; Andrew G Clark
Journal:  Pharmacogenetics       Date:  2003-08

10.  Common germline MDR1/ABCB1 functional polymorphisms and haplotypes modify susceptibility to colorectal cancers with high microsatellite instability.

Authors:  Uros Potocnik; Damjan Glavac; Michael Dean
Journal:  Cancer Genet Cytogenet       Date:  2008-05
View more
  23 in total

1.  MDR1 C3435T polymorphism and cancer risk: a meta-analysis based on 39 case-control studies.

Authors:  Xiaojing Sheng; Limei Zhang; Na Tong; Dewei Luo; Meilin Wang; Min Xu; Zhengdong Zhang
Journal:  Mol Biol Rep       Date:  2012-02-04       Impact factor: 2.316

2.  Genetic variability and haplotype profile of MDR1 in Saudi Arabian males.

Authors:  Abdullah M Al-Mohizea; Khalid M Alkharfy; Khawla M Bagulb; Amal M Alghamdi; Fahad I Al-Jenoobi; Saleh Al-Muhsen; Rabih Halwani; Mohammad Khalid Parvez; M Khalid Parvez; Mohammed S Al-Dosari
Journal:  Mol Biol Rep       Date:  2012-10-07       Impact factor: 2.316

Review 3.  Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years.

Authors:  Mariusz Panczyk
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

4.  ABCB1/MDR1 gene polymorphisms as a prognostic factor in colorectal cancer.

Authors:  Ewa Balcerczak; Mariusz Panczyk; Sylwester Piaskowski; Grazyna Pasz-Walczak; Aleksandra Sałagacka; Marek Mirowski
Journal:  Int J Colorectal Dis       Date:  2010-06-09       Impact factor: 2.571

5.  Polymorphisms of xenobiotic-metabolizing and transporter genes, and the risk of gastric and colorectal cancer in an admixed population from the Brazilian Amazon.

Authors:  Amanda Nazaré Cohen Lima de Castro; Marianne Rodrigues Fernandes; Darlen Cardoso de Carvalho; Tatiane Piedade de Souza; Juliana Carla Gomes Rodrigues; Roberta Borges Andrade; Antonio Andre Conde Modesto; Sidney Santos; Paulo Pimentel Assumpção; Ney Pereira Carneiro Dos Santos
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

6.  Association between the C3435T polymorphism of ABCB1/MDR1 gene (rs1045642) and colorectal cancer susceptibility : a meta-analysis based on 11,339 subjects.

Authors:  Li Zhao; Kai Li; Wusheng Li; Zhen Yang
Journal:  Tumour Biol       Date:  2013-03-16

7.  Impact of ABCB1 Gene (C3435T/A2677G) Polymorphic Sequence Variations on the Outcome of Patients with Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia in Kashmiri Population: A Case-Control Study.

Authors:  Shahid M Baba; Arshad A Pandith; Zafar A Shah; Sajad A Geelani; Mohammad Muzaffar Mir; Javid Rasool Bhat; Gul Mohammad Bhat
Journal:  Indian J Hematol Blood Transfus       Date:  2020-05-26       Impact factor: 0.900

8.  A comprehensive investigation on common polymorphisms in the MDR1/ABCB1 transporter gene and susceptibility to colorectal cancer.

Authors:  Daniele Campa; Juan Sainz; Barbara Pardini; Ludmila Vodickova; Alessio Naccarati; Anja Rudolph; Jan Novotny; Asta Försti; Stephan Buch; Witigo von Schönfels; Clemens Schafmayer; Henry Völzke; Michael Hoffmeister; Bernd Frank; Roberto Barale; Kari Hemminki; Jochen Hampe; Jenny Chang-Claude; Hermann Brenner; Pavel Vodicka; Federico Canzian
Journal:  PLoS One       Date:  2012-03-02       Impact factor: 3.240

9.  Colorectal cancer susceptibility: apparent gender-related modulation by ABCB1 gene polymorphisms.

Authors:  Marcella Martinelli; Luca Scapoli; Francesca Cura; Maria Teresa Rodia; Giampaolo Ugolini; Isacco Montroni; Rossella Solmi
Journal:  J Biomed Sci       Date:  2014-09-04       Impact factor: 8.410

10.  The association between polymorphisms in the MDR1 gene and risk of cancer: a systematic review and pooled analysis of 52 case-control studies.

Authors:  Ling-Hui Wang; Yan-Bin Song; Wen-Ling Zheng; Ling Jiang; Wen-Li Ma
Journal:  Cancer Cell Int       Date:  2013-05-20       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.